Evaluation of apremilast in chronic pruritus of unknown origin: A proof-of-concept, phase 2a, open-label, single-arm clinical trial

Health Sci Rep. 2020 Apr 23;3(2):e154. doi: 10.1002/hsr2.154. eCollection 2020 Jun.
No abstract available